Caris Life Sciences, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
CAI Nasdaq 2830 www.carislifesciences.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Caris Life Sciences, Inc.

Biomarker Collaboration and Licensing Deals Report 2016-2026 - Featuring Quanterix, Caris Life Sciences, Alnylam Pharmaceuticals, Guardant Health, Eurofins Scientific and More - Jul 21st, 2026 10:28 am
Caris Life Sciences (CAI) Stock Looks Undervalued On A 47% Slump - Jul 17th, 2026 2:09 pm
Caris Life Sciences (CAI) Sets August Results Date, Is The Stock Undervalued? - Jul 17th, 2026 8:10 am
Caris Life Sciences (CAI) Launches In House PTEN Test After FDA Prostate Cancer Approval - Jul 17th, 2026 5:12 am
Caris Life Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026 - Jul 16th, 2026 6:30 am
Caris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC Testing - Jul 14th, 2026 6:30 am
Caris Life Sciences (CAI) Launches Caris Detect Multi-Cancer Screening Test - Jul 10th, 2026 7:59 am
Caris Life Sciences Launches Caris Detect, the World's Most Sensitive and Comprehensive Multi-Cancer Early Detection Blood Test - Jul 1st, 2026 6:30 am
Is Caris Life Sciences, Inc. (CAI) Stock Positioned for Growth With AI-Driven Precision Medicine Expansion? - Jun 30th, 2026 7:07 am
Is Caris Life Sciences, Inc. (CAI) A Good Stock To Buy Now? - Jun 19th, 2026 8:59 am
Caris Life Sciences (CAI) Announces $100M Share Repurchase Program - Jun 17th, 2026 1:38 pm
Caris Life Sciences Announces That It’s Dual Listing on NYSE Texas - Jun 16th, 2026 9:26 am
Caris Life Sciences Announces Dual Listing on NYSE Texas - Jun 16th, 2026 6:30 am
Caris Life Sciences Announces Share Repurchase Program - Jun 8th, 2026 6:30 am
Caris Life Sciences Launches Behind the Diagnosis Campaign Spotlighting Patient Lives Transformed by Caris' Comprehensive Genomic Testing - May 26th, 2026 6:30 am
You’ve Likely Never Heard of Caris Life Sciences Stock. Billionaire Stanley Druckenmiller Has – and He Likes What He Sees. - May 20th, 2026 11:34 am
Caris Life Sciences Advances Precision Oncology As Shares Trade Below Targets - May 19th, 2026 1:06 pm
Another billionaire dumps mega-cap stock for AI bet - May 17th, 2026 8:03 pm
Stanley Druckenmiller Just Exited Alphabet. TCI Fund Management Is Buying. - May 15th, 2026 3:59 pm
Caris Life Sciences Publishes Study on the Caris Lookback Program Demonstrating the Ongoing Clinical Value of Comprehensive Testing with Caris MI Cancer Seek - May 15th, 2026 6:30 am